You are here: Home » Markets » News
Business Standard

Bajaj Healthcare zooms 20%, hits new high on strong June quarter results

Ebitda margin improved to 18.77 per cent from 10.23 per cent in the previous year quarter

Topics
Buzzing stocks | Markets

SI Reporter  |  Mumbai 

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Representative image

Shares of Bajaj Healthcare zoomed 20 per cent to a new high of Rs 498.35 on the BSE on Tuesday after the company reported a five-fold jump in net profit at Rs 15.29 crore in the June quarter (Q1FY21), on the back of strong revenue growth. The pharmaceutical company had posted profit of Rs 3.24 crore in the year-ago quarter.

The company’s revenue from operations during the quarter under review grew 52 per cent to Rs 140 crore against Rs 92 crore in the corresponding quarter of previous fiscal. Ebitda (earnings before interest, taxes, depreciation, and amortization) margin improved to 18.77 per cent from 10.23 per cent in previous year quarter.

Rating agency Crisil has ‘positive’ outlook on Bajaj Healthcare, as it expects improvement in business risk profile over the medium term. According to Crisil, healthy demand, better realisations coupled with wider product portfolio through acquisitions and enhanced capacities, should result in higher revenue and profitability.

Demand for key products of the company such as Ascorbic acid (Active pharmaceutical ingredient for Vitamin C) and CH Base (raw material for manufacturing sanitiser) have exhibited substantial improvement amidst Covid-19 pandemic. Further, the manufacturing operations were not much impacted by lockdown and other measures taken by central and state governments to contain the spread of the Covid-19, since the company operates in the essential segment. Timely commencement of newly acquired capacities and sustenance of revenue growth and profitability shall remain key rating sensitivity, the rating agency said.

In the past three months, Bajaj Healthcare's stock has rallied 91 per cent, as compared to 17 per cent rise in the S&P BSE Sensex.

At 10:25 am, the stock was trading 12 per cent higher at Rs 465, against 0.35 per cent gain in the benchmark index. The trading volumes on the counter jumped four-fold with 112,000 shares changing hands so far on the BSE.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, September 15 2020. 10:28 IST
RECOMMENDED FOR YOU
.